Angiomax and activated partial thromboplastin time prolonged Patient Reports February 13, 2012
Angiomax Side Effects Report #5655672-0
Angiomax side effect was reported by a Physician from UNITED STATES on Nov 09, 2007. Male patient, 71 years of age, was diagnosed with therapeutic procedure and was treated with Angiomax. After drug was administered, patient experienced the following side effects: activated partial thromboplastin time prolonged, international normalised ratio increased. Angiomax dosage: 1 MG/KG, HR, INTRAVENOUS. During the same period patient was treated with RETEPLASE, HEPARIN. Patient recovered.
Angiomax Side Effects Report #5859000-7
Angiomax side effect was reported by a Consumer or non-health professional from UNITED STATES on Aug 13, 2008. Male patient, 80 years of age, was diagnosed with percutaneous coronary intervention and was treated with Angiomax. After drug was administered, patient experienced the following side effects: activated partial thromboplastin time prolonged, coronary artery dissection, iatrogenic injury. Angiomax dosage: 0.75 MG/KG, BOLUS, INTRAVENOUS; 1.75 MG/KG, HR, INTRAVENOUS; 0.5 MG/KG, HR, INTRAVENOUS. During the same period patient was treated with PLAVIX. Patient recovered.
Angiomax Side Effects Report #5164853-4
Angiomax side effect was reported by a Physician from UNITED STATES on Nov 14, 2006. Female patient, 74 years of age, was diagnosed with percutaneous coronary intervention and was treated with Angiomax. After drug was administered, patient experienced the following side effects: abnormal clotting factor, activated partial thromboplastin time prolonged, coagulation factor decreased, coagulation time prolonged, gastrointestinal haemorrhage, haematoma, international normalised ratio increased, prothrombin time prolonged. Angiomax dosage: unknown. During the same period patient was treated with ASPIRIN, PLAVIX. Patient was hospitalized. Patient recovered.
Angiomax Side Effects Report #6086048-2
Angiomax side effect was reported by a Health Professional from UNITED STATES on Dec 01, 2008. Male patient, 45 years of age, was diagnosed with percutaneous coronary intervention and was treated with Angiomax. After drug was administered, patient experienced the following side effects: activated partial thromboplastin time prolonged, cerebral haemorrhage, international normalised ratio abnormal, prothrombin time prolonged. Angiomax dosage: 18.6 ML, BOLUS, INTRAVENOUS, 4.2 ML, HR, INTRAVENOUS. During the same period patient was treated with PLAVIX, ASPIRIN. Patient died on 11/03/2008.
Angiomax Side Effects Report #6026031-6
Angiomax side effect was reported by a Physician from UNITED STATES on Dec 09, 2008. Female patient was diagnosed with percutaneous coronary intervention and was treated with Angiomax. After drug was administered, patient experienced the following side effects: activated partial thromboplastin time prolonged, myocardial infarction. Angiomax dosage: 0.1 MG/KG, BOLUS, INTRAVENOUS, 0.25 MG/KG, HR FOR MIN 72H, INTRAVENOUS. During the same period patient was treated with ASPIRIN. Patient died.
Angiomax Side Effects Report #5309602-1
Angiomax side effect was reported by a Pharmacist from UNITED STATES on Apr 11, 2007. Male patient, 75 years of age, was diagnosed with heparin-induced thrombocytopenia and was treated with Angiomax. After drug was administered, patient experienced the following side effects: activated partial thromboplastin time prolonged, gastrointestinal haemorrhage, gastrointestinal perforation, renal failure. Angiomax dosage: unknown. Patient recovered.
Angiomax Side Effects Report #5327397-2
Angiomax side effect was reported by a Pharmacist from UNITED STATES on Apr 27, 2007. Male patient, 75 years of age, was diagnosed with heparin-induced thrombocytopenia and was treated with Angiomax. After drug was administered, patient experienced the following side effects: activated partial thromboplastin time prolonged, gastrointestinal haemorrhage, gastrointestinal perforation. Angiomax dosage: unknown. Patient recovered.
Angiomax Side Effects Report #5322086-2
Angiomax side effect was reported by a Consumer or non-health professional from UNITED STATES on Apr 23, 2007. Female patient was diagnosed with heparin-induced thrombocytopenia and was treated with Angiomax. After drug was administered, patient experienced the following side effects: activated partial thromboplastin time prolonged, embolism, gastrointestinal haemorrhage, heparin-induced thrombocytopenia, hepatic failure, international normalised ratio decreased, organ failure, renal failure. Angiomax dosage: 0.21 MG/KG, HR (MEAN INITIATION DOSE), INTRAVENOUS. During the same period patient was treated with ARGATROBAN, LEPIRUDIN. Patient died.
Angiomax Side Effects Report #4899685-5
Angiomax side effect was reported by a Health Professional from UNITED STATES on Jan 19, 2006. Male patient, 84 years of age, weighting 155.0 lb, was diagnosed with coronary arterial stent insertion and was treated with Angiomax. After drug was administered, patient experienced the following side effects: activated partial thromboplastin time prolonged, cardiac arrest
, hypotension, reperfusion injury, thrombosis. Angiomax dosage: 0.75 MG/KG, BOLUS, IV BOLUS; 1.75 MG/KG/HR; INTRAVENOUS. During the same period patient was treated with ASPIRIN, PLAVIX, TENORMIN, LASIX, LIPITOR, FENTANYL, VERSED. Patient was hospitalized. Patient recovered.Angiomax Side Effects Report #5708911-1
Angiomax side effect was reported by a Health Professional from UNITED STATES on Apr 03, 2008. Female patient, 84 years of age, weighting 123.0 lb, was diagnosed with acute myocardial infarction, percutaneous coronary intervention and was treated with Angiomax. After drug was administered, patient experienced the following side effects: activated partial thromboplastin time prolonged, anaemia, haematoma, operative haemorrhage, overdose, procedural complication, vascular pseudoaneurysm. Angiomax dosage: 0.75 MG/KG, SINGLE, IV BOLUS; 1.75 MG/KG, HR, INTRAVENOUS. During the same period patient was treated with LISINOPRIL, ASPIRIN, CALCIUM, HYDROCHLOROTHIAZIDE, ACETAMINOPHEN. Patient recovered.
Angiomax Side Effects Report #5664136-X
Angiomax side effect was reported by a Physician from UNITED STATES on Feb 25, 2008. Male patient, 59 years of age, was diagnosed with coronary artery bypass
, coagulopathy, haemorrhage and was treated with Angiomax. After drug was administered, patient experienced the following side effects: activated partial thromboplastin time prolonged, akinesia, anoxic encephalopathy, atrial thrombosis, cardiac tamponade, coagulopathy, cranial nerve disorder, dilatation ventricular, grand mal convulsion. Angiomax dosage: 0.63 MG/KG, SINGLE, IV BOLUS. During the same period patient was treated with LEPIRUDIN, FACTOR VIIA, FACTOR VIIA, APROTININ, HEPARIN, EPINEPHRINE, DOPAMINE. Patient recovered.Angiomax Side Effects Report #5484470-6
Angiomax side effect was reported by a Consumer or non-health professional from UNITED STATES on Sept 27, 2007. Female patient, 54 years of age, weighting 110.2 lb, was treated with Angiomax. After drug was administered, patient experienced the following side effects: activated partial thromboplastin time prolonged, coagulation time prolonged, coronary artery perforation, international normalised ratio increased, prothrombin time prolonged. Angiomax dosage: 8.3 ML BOLUS, IV BOLUS; 15.3 ML HR, INTRAVENOUS. During the same period patient was treated with HEPARIN. Patient recovered.
Angiomax Side Effects Report #5322092-8
Angiomax side effect was reported by a Consumer or non-health professional from UNITED STATES on Apr 23, 2007. Female patient was treated with Angiomax. After drug was administered, patient experienced the following side effects: activated partial thromboplastin time prolonged, dialysis
, embolism, gastrointestinal haemorrhage, heparin-induced thrombocytopenia, hepatic failure, international normalised ratio decreased, organ failure. Angiomax dosage: 0.21 MG/KG, HR (MEAN INITIATION DOSE), INTRAVENOUS. During the same period patient was treated with ARGATROBAN, LEPIRUDIN. Patient died.
Angiomax and activated partial thromboplastin time prolonged 